About this event
Join our distinguished panel of world-renowned experts for an interactive conversation on the latest updates of diabetes care.
In this one-hour moderated symposium, expert speakers will discuss how sensor-based technology can make a difference to your work and in your patients’ lives.
Explore the clinical value and benefits of CGM for managing the different stages in type 2 diabetes.
Discover the glucose insights CGM may offer for managing your diabetes patients at cardiovascular risk and CGM as a powerful complement to existing type 2 therapies.
Experience interactive clinical cases and learn how the AGP report can be used for type 2 diabetes therapy adjustment.
The session will close with an open Q&A with our panel of experts.
All rights reserved. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott.
© 2024 Abbott. ADC-94782 v2.0
Hosted by
-
Guest speaker
Dr. Virginia BellidoG
Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío, Seville, Spain
-
Guest speaker
Prof. Stefano Del PratoG
Interdisciplinary Research Center "Health Science", Sant'Anna School of Advanced Studies, Pisa, Italy
-
Guest speaker
Prof. Ramzi AjjanG
Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds and Leeds Teaching Hospitals Trust, Leeds, United Kingdom
-
Guest speaker
Prof. Robert StoreyG
School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom
Abbott
At Abbott, we’re focused on making breakthrough technology accessible and approachable for all. Our sensing technology has revolutionized how people monitor glucose and provides doctors with more data for better informed treatment decisions
